Macrophage-Derived Exosomal Mir-155 Regulating Cardiomyocyte Pyroptosis and Hypertrophy in Uremic Cardiomyopathy

[Display omitted] •miR-155 was synthesized and loaded into exosomes in increased infiltration of macrophages in a uremic heart.•The released exosomal fusion with the plasma membrane leads to the release of miR-155 into the cytosol and translational repression of forkhead transcription factors of the...

Full description

Saved in:
Bibliographic Details
Published inJACC. Basic to translational science Vol. 5; no. 2; pp. 148 - 166
Main Authors Wang, Bin, Wang, Ze-Mu, Ji, Jia-Ling, Gan, Weihua, Zhang, Aiqing, Shi, Hao-Jie, Wang, Hao, Lv, Linli, Li, Zuolin, Tang, Taotao, Du, Jie, Wang, Xiaonan H., Liu, Bi-Cheng
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •miR-155 was synthesized and loaded into exosomes in increased infiltration of macrophages in a uremic heart.•The released exosomal fusion with the plasma membrane leads to the release of miR-155 into the cytosol and translational repression of forkhead transcription factors of the O class in cardiomyocytes.•Macrophage-derived miR-155–containing exosomes promoted cardiomyocyte pyroptosis and uremic cardiomyopathy changes (cardiac hypertrophy and fibrosis) by directly targeting FoxO3a in uremic mice. Inhibiting secretion from macrophage-derived miR-155–containing exosomes represents a novel therapeutic strategy for the management of uremic cardiomyopathy. miR-155 was synthesized and loaded into exosomes in increased infiltration of macrophages in a uremic heart. The released exosomal fusion with the plasma membrane leads to the release of miR-155 into the cytosol and translational repression of forkhead transcription factors of the O class (FoxO3a) in cardiomyocytes. Finally, macrophage-derived miR-155–containing exosomes promoted cardiomyocyte pyroptosis and uremic cardiomyopathy changes (cardiac hypertrophy and fibrosis) by directly targeting FoxO3a in uremic mice.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Drs. B. Wang and Z.-M. Wang contributed equally to this work and are joint first authors.
ISSN:2452-302X
2452-302X
DOI:10.1016/j.jacbts.2019.10.011